Offering unique exposure at competitive prices: Biolase Inc (BIOL) Stock

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

Will Earnings Beat Estimates? Biolase Inc (BIOL) Stock

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

There Is Nothing Like Biolase Inc (BIOL) Stock

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

Biolase Inc (BIOL) Stock: Values And Value Intersection

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

What makes Biolase Inc (BIOL) Stock unique?

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

Biolase Inc (BIOL) Stock creates opportunities due to its volume and complexity

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

Is it possible to sustain this rally? Biolase Inc (BIOL) Stock

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]

Are you thinking about selling now? Biolase Inc (BIOL) Stock

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as […]

A Tale from the Dusty Corner: Biolase Inc (BIOL) Stock

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as […]

Is Biolase Inc (BIOL) Stock Paving the Way for Earnings?

The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as […]